BMJ  2004;329:458-459 (21 August), doi:10.1136/bmj.329.7463.458-b

Letter

Balancing benefits and harms in health care

Summary of webchat

The first 150 words of the full text of this article appear below.

A webchat on the benefits and harms issue took place on 8 July 2004.1 The editors of the theme issue began by raising several topics for discussion.

  1. Should complementary and alternative medicine have featured as much as other aspects? Would their recognition improve evidence about their benefits and harms?
  2. How will the European Trials Directive affect trials focusing on the safety of treatments?
  3. Has anyone tried to report adverse effects in a developing country?
  4. What is the role of consumers (patients) in determining an acceptable ratio of benefit to harm?
  5. Should vulnerable populations in whom drugs are not licensed such as pregnant women, children, and elderly people be considered?

The topic that dominated the webchat for most of its duration and informed whatever other ideas were raised was, however, government intervention in health care, exemplified by fortification of bread with folic acid and perhaps also vitamin B12. Participants expressed surprise . . . [Full text of this article]

Birte Twisselmann, technical editor

BMJ


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study
C van Walraven, M M Mamdani, P S Wells, and J I Williams
BMJ 2001 323: 655. [Abstract] [Full Text] [PDF]

Access jobs at BMJ Careers
Whats new online at Student BMJ